Zhu J - Search Results

1

PFKP confers chemoresistance by upregulating ABCC2 transporter in non-small cell lung cancer.

Wang Z, Wu S, Chen X, Liang J, Xue F, Cho WC, Bao J, Chen B, Ye M, Ma D, Zhu C, Zhu J, Shen J. Wang Z, et al. Among authors: zhu c, zhu j. Transl Lung Cancer Res. 2023 Nov 30;12(11):2294-2309. doi: 10.21037/tlcr-23-567. Epub 2023 Nov 24. Transl Lung Cancer Res. 2023. PMID: 38090515 Free PMC article.

2

An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.

Wu G, Song L, Zhu J, Hu Y, Cao L, Tan Z, Zhang S, Li Z, Li J. Wu G, et al. Among authors: zhu j. Cancer Res. 2018 Nov 15;78(22):6399-6412. doi: 10.1158/0008-5472.CAN-18-2063. Epub 2018 Sep 25. Cancer Res. 2018. PMID: 30254148

3

Targeting TRIM54/Axin1/β-Catenin Axis Prohibits Proliferation and Metastasis in Hepatocellular Carcinoma.

Zhu J, Wu Y, Lao S, Shen J, Yu Y, Fang C, Zhang N, Li Y, Zhang R. Zhu J, et al. Front Oncol. 2021 Dec 9;11:759842. doi: 10.3389/fonc.2021.759842. eCollection 2021. Front Oncol. 2021. PMID: 34956880 Free PMC article.

4

Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma.

Ren S, Wang J, Xu A, Bao J, Cho WC, Zhu J, Shen J. Ren S, et al. Among authors: zhu j. Cell Oncol (Dordr). 2022 Feb;45(1):57-67. doi: 10.1007/s13402-021-00648-3. Epub 2022 Jan 13. Cell Oncol (Dordr). 2022. PMID: 35025009

5

MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma.

Zhu J, Wu Y, Yu Y, Li Y, Shen J, Zhang R. Zhu J, et al. Cell Death Dis. 2022 Aug 20;13(8):727. doi: 10.1038/s41419-022-05180-2. Cell Death Dis. 2022. PMID: 35987690 Free PMC article.

6

ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways.

Zhu J, Qiu X, Jin X, Nie X, Ou S, Wu G, Shen J, Zhang R. Zhu J, et al. Cell Oncol (Dordr). 2024 Oct;47(5):1927-1942. doi: 10.1007/s13402-024-00976-0. Epub 2024 Aug 14. Cell Oncol (Dordr). 2024. PMID: 39141315

7

miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer.

Jiang L, Yu L, Zhang X, Lei F, Wang L, Liu X, Wu S, Zhu J, Wu G, Cao L, Liu A, Song L, Li J. Jiang L, et al. Among authors: zhu j. Cancer Res. 2016 Mar 1;76(5):1101-11. doi: 10.1158/0008-5472.CAN-15-1770. Epub 2016 Jan 8. Cancer Res. 2016. PMID: 26747895

8

Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.

Liu A, Zhu J, Wu G, Cao L, Tan Z, Zhang S, Jiang L, Wu J, Li M, Song L, Li J. Liu A, et al. Among authors: zhu j. Mol Cancer. 2017 Jun 21;16(1):106. doi: 10.1186/s12943-017-0669-9. Mol Cancer. 2017. PMID: 28633632 Free PMC article.

9

miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways.

Zhang X, Ren D, Wu X, Lin X, Ye L, Lin C, Wu S, Zhu J, Peng X, Song L. Zhang X, et al. Among authors: zhu j. Mol Ther Nucleic Acids. 2018 Jun 1;11:142-158. doi: 10.1016/j.omtn.2018.01.004. Epub 2018 Jan 31. Mol Ther Nucleic Acids. 2018. PMID: 29858050 Free PMC article.

10

NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer.

Zhu J, Wu G, Song L, Cao L, Tan Z, Tang M, Li Z, Shi D, Zhang S, Li J. Zhu J, et al. EBioMedicine. 2019 May;43:238-252. doi: 10.1016/j.ebiom.2019.04.041. Epub 2019 Apr 29. EBioMedicine. 2019. PMID: 31047858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,244 results

Search Page

Filters